Table 5 Score differences between cancer and non-cancer cohorts.

Willingness to participate, overall

41.2 ± 25.4

39.8 ± 25.4

0.434

   New and unmarketed drug trials

31.9 ± 27.6

27.4 ± 26.3

0.021

   Marketed drug with new indication trials

44.0 ± 28.3

40.2 ± 28.8

0.068

   Medical procedure trials

43.7 ± 27.1

43.9 ± 28.0

0.893

   Medical device trials

43.8 ± 27.5

45.2 ± 8.3

0.487

   General clinical trials

42.7 ± 26.6

42.1 ± 27.8

0.766

Knowledge

28.9 ± 34.6

31.0 ± 39.0

0.436

Perceived benefits

65.6 ± 13.5

66.7 ± 12.5

0.065

Perceived risks

71.3 ± 17.5

73.4 ± 17.8

0.098

Confidence in clinical trial conducts

66.0 ± 14.5

66.7 ± 14.4

0.482

Religious barriers

51.4 ± 15.5

48.3 ± 16.1

0.006